Yama Yar is the Global Maintenance & Reliability Lead at Aenova Group, where he drives global strategies to enhance equipment reliability, streamline maintenance processes, and optimize operational efficiency across the organization. With extensive experience in maintenance leadership and operational excellence, including senior roles at Nestlé Health Science and leading consultancies, he brings a proven track record of implementing scalable solutions that improve performance and reduce downtime.

At Aenova, Yama focuses on building a future-ready maintenance framework that supports growth and resilience across the company’s international network.

The Aenova Group is a leading global contract manufacturer and development services provider for the pharmaceutical and healthcare industry. Our services include end-to-end manufacturing and development of all dosage forms and potency levels (ranging from nutraceuticals to high-potents) out of 14 sites in Europe and the US. With our comprehensive know-how, many years of experience, well-trained staff of 4,000 employees, innovative technologies and highest quality standards we are a reliable, long-term partner to pharmaceutical and consumer health care customers around the world, both in the human and veterinary healthcare market Our products and behaviour affect and improve the health and well-being of millions of patients, and their families around the world. Our customers entrust us with the responsibility to deliver life-saving or life-enhancing products. We come to work every day to serve these customers, but ultimately, because we passionately care about their patients. Aenova was created 2008, as a merger of pharmaceutical companies Dragenopharm and Swiss Caps, forming the nucleus of the group. In 2012, the Temmler Group was acquired, and at the beginning of 2014 Haupt Pharma was acquired. The majority shareholder of Aenova is Kühne Holding AG.